Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,608 across all filing types
Latest filing 2020-06-10 Regulatory Filings
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
109年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (中化生) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains tabulated financial data but is very short (602 characters) and focuses on specific financial guarantees and loans rather than comprehensive financial statements or management discussion. There is no indication of it being an annual or quarterly report, audit report, or earnings release. It is a regulatory disclosure related to financing activities but does not announce new financing or capital changes. Given the nature of the data and the short length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2020-06-10 Chinese
109年5月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 中化生 for the period of May 2020 (民國109年05月). It includes comparative figures from the previous year and percentage changes. The document is short (769 characters) and primarily presents financial data in a tabular format without detailed financial statements or management discussion. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement or certification. It is a periodic financial summary report with actual financial data for a short period (monthly and year-to-date). Therefore, it fits best as an Interim / Quarterly Report (IR). Q1 2020
2020-06-10 Chinese
公告本公司受邀參加富邦證券舉辦之線上法人說明會
Investor Presentation Classification · 95% confidence The document is a short announcement (625 characters) about the company 1762 中化生 being invited to participate in an online investor presentation hosted by Fubon Securities. It specifies the date and time of the event and mentions that the presentation will cover the company's Q1 financial and business information. It also directs readers to the official disclosure site for the full presentation details. There is no actual financial data or detailed report content included in this text. According to the 'Menu vs Meal' rule, this is an announcement of an investor presentation event, not the presentation itself or a financial report. Therefore, the appropriate classification is Investor Presentation (IP).
2020-06-10 Chinese
公告本公司109年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a short announcement (676 characters) reporting the important resolutions from the company's Annual General Meeting (AGM) held on 109/05/29. It includes details such as dividend distribution, approval of the business report and financial statements, and amendments to shareholder meeting rules. There is no full report or detailed financial statements included, only a summary of AGM decisions. According to the rules, such a document is classified as Declaration of Voting Results & Voting Rights Announcements (DVA), since it reports official results from shareholder votes at the AGM. The document is not the full Annual Report or financial report itself, nor is it a presentation or proxy statement. Confidence is high due to clear keywords like '股東常會重要決議事項' (important resolutions of the shareholders meeting) and the nature of the content.
2020-05-29 Chinese
108年度股利金額(股東會決議)
Notice of Dividend Amount Classification · 100% confidence The document contains detailed information about dividend distribution, including cash dividends per share, dates of board resolutions and shareholder meetings, and explanations of dividend policies. It is a formal announcement of dividend amounts and payment details for shareholders. The document length is short (1963 characters) and focuses solely on dividend distribution data without financial statements or broader financial performance analysis. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2020-05-29 Chinese
因本公司有價證券於集中交易市場達公布注意交易資訊標準, 故公布相關財務業務等重大訊息,以利投資人區別瞭解。
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (1762 中化生) disclosing significant financial information due to the securities reaching a threshold for attention on the Taiwan Stock Exchange. It provides summarized financial data for recent periods, including monthly, quarterly, and four-quarter cumulative figures, but it is brief (1402 characters) and does not contain a full financial report or detailed analysis. It is a disclosure of material financial information to investors rather than a full financial report like an Interim/Quarterly Report (IR) or Annual Report (10-K). The document also references compliance with Taiwan Stock Exchange regulations for disclosure. Given the short length and nature of the content, this fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-21 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.